EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting p53-Driven FOXM1 Suppresses Tumor Growth and Synergistically Sensitizes to Chemotherapy in Triple-Negative Breast Cancer Models

Sayra Dilmac, Nermin Kahraman, Ferah Comert Onder iD, Ogun Ali Gul, Bulent Ozpolat

Cells · 09.07.2026 · 15 (14) · 1237

DOI: 10.3390/cells15141237 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 09.07.2026. Verfasst von Sayra Dilmac und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Forkhead Box Protein M1, Triple Negative Breast Neoplasms, Tumor Suppressor Protein p53, Antineoplastic Agents. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is characterized by a lack of estrogen, progesterone, and HER2 receptors; an aggressive phenotype; high rates of early relapse and metastasis; and the worst mortality rates among all breast cancer subtypes. Currently, there is no effective curative targeted therapy for TNBC and chemotherapy remains the primary treatment for TNBC. Therefore, there is a critical need to develop highly effective, novel therapies to improve patient survival. We previously validated FOXM1, a proto-oncogenic transcription factor, for the first time as a potential molecular target in TNBC through genetic knockdown studies in mice. We show that FOXM1 expression is associated with shorter patient survival and is a marker of poor prognosis. There is no FDA-approved FOXM1 inhibitor. We found that patients with TP53 mutations have dramatically higher FOXM1 expression, indicating that widespread TP53 mutations detected in about 80% of TNBC patients are the major driver of FOXM1 overexpression in TNBC patients. We identified its binding ability using an in silico study, and found it to be a well-known FOXM1 inhibitor that suppresses TNBC cell proliferation, migration, and invasion, and induces apoptosis. In vivo studies in mice bearing TNBC tumors demonstrated that treatment with a novel FOXM1 inhibitor incorporated in single-lipid nanoparticles suppressed the growth of TNBC tumor xenografts. In conclusion, our findings suggest that the novel FOXM1 inhibitor represents a potent and safe therapeutic strategy with significant potential for the treatment of other FOXM1-driven cancers including TNBC that currently have limited treatment options.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Forkhead Box Protein M1Triple Negative Breast NeoplasmsTumor Suppressor Protein p53Antineoplastic AgentsHumansAnimalsFemaleCell ProliferationMiceCell Line, TumorGene Expression Regulation, NeoplasticXenograft Model Antitumor AssaysApoptosisMice, Nude

Stichwörter der Autor:innen

FOXM1FOXM1 inhibitorTNBCsmall molecule inhibitor

Substanzen

Forkhead Box Protein M1Tumor Suppressor Protein p53FOXM1 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA.
  • Stephenson School of Biomedical Engineering, The University of Oklahoma, Norman, OK 73019, USA.
  • Department of Medical Biology, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale 17100, Türkiye.
  • Department of Experimental Therapeutics, MD Anderson Cancer Center, The University of Texas, Houston, TX 77054, USA.

ORCID-Profile: Ferah Comert Onder

Zitieren

APA

Dilmac, S., Kahraman, N., Onder, F. C., Gul, O. A., & Ozpolat, B. (2026). Targeting p53-Driven FOXM1 Suppresses Tumor Growth and Synergistically Sensitizes to Chemotherapy in Triple-Negative Breast Cancer Models. Cells, 15(14), 1237. https://doi.org/10.3390/cells15141237

Vancouver

Dilmac S, Kahraman N, Onder FC, Gul OA, Ozpolat B. Targeting p53-Driven FOXM1 Suppresses Tumor Growth and Synergistically Sensitizes to Chemotherapy in Triple-Negative Breast Cancer Models. Cells. 2026;15(14):1237. doi:10.3390/cells15141237

BibTeX
@article{Dilmac2026,
  author = {Dilmac, Sayra and Kahraman, Nermin and Onder, Ferah Comert and Gul, Ogun Ali and Ozpolat, Bulent},
  title = {Targeting p53-Driven FOXM1 Suppresses Tumor Growth and Synergistically Sensitizes to Chemotherapy in Triple-Negative Breast Cancer Models},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {14},
  pages = {1237},
  doi = {10.3390/cells15141237}
}
Kostenlos starten →